Passez à l'illimité avec Magzter GOLD
Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement
Essayer OR - Gratuit
Zydus sees vaccines, medical devices as new growth drivers
Mint Mumbai
|May 22, 2025
Zydus expects to outperform the Indian pharma market in FY26, while projecting single-digit growth in the US
Zydus Lifesciences Ltd is looking to ramp up its vaccines and medtech portfolio over the next few years, the company's top executive told investors during an earnings call Tuesday evening.
The drugmaker, which announced its Q4FY25 results the same day, expects double-digit revenue growth in FY26, led by strong performance in both domestic and international markets, as well as newer businesses such as biologics, vaccines, and medtech.
"...led by strong growths in India and international markets and also our new growth themes like biologics, vaccines and all scaling up," said managing director Sharvil Patel.
The company expects to outperform the Indian pharmaceutical market in FY26, while projecting single-digit growth in the US.
Cette histoire est tirée de l'édition May 22, 2025 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
Defence signals
The US has approved the sale of Excalibur projectiles and Javelin missile systems to India in a deal valued at about $93 million, according to the US Defense Security Cooperation Agency.
1 min
November 21, 2025
Mint Mumbai
Small loans against property begin to sour for non-banks
Indian lenders are seeing the stress in their microfinance books gradually spread to their secured portfolios as overleveraged customers delay repayments. This comes less than a year after the Reserve Bank of India warned of a spillover.
3 mins
November 21, 2025
Mint Mumbai
LIFE OF VI: HOW INDIA AVERTED A TELCO DUOPOLY
The inside story of how the Centre created a limited legal reopening to prevent Vi's collapse
9 mins
November 21, 2025
Mint Mumbai
Kirin in talks to recast B9, has no plan to sell stake
Japan's Kirin Holdings, among the largest shareholder in B9 Beverages, that operates Bira, is holding joint discussions with stakeholders and creditors of the beer-maker to restructure the existing business including the management and business strategy as the company navigates a funding crunch and employee unrest.
2 mins
November 21, 2025
Mint Mumbai
Cracks are appearing in OpenAI’s dominant facade
THE 21ST-CENTURY tech landscape was built with a winner-takes-all mindset. It started with Microsoft’s Windows monopoly at the end of the 1990s. Since then Alphabet-owned Google has cornered search and Amazon has become the king of e-commerce. Meta, too, has blanketed much of the world with social media—though on November 18th, a judge in Washington, DC, spared it the ignominy of being declared a monopolist.
2 mins
November 21, 2025
Mint Mumbai
DATA RECAP: THE WEEK IN CHARTS
From widening trade gaps caused by US tariff headwinds and surging gold imports, to a rise in the urban unemployment rate in October, shifting consumption patterns in the economy
2 mins
November 21, 2025
Mint Mumbai
Automation hits tech jobs as GCCs dial back on hiring
Automation is beginning to reshape India's tech-hiring landscape, with global capability centres (GCCs) pulling back on routine recruitment-intensifying the slowdown already hitting large staffing firms dependent on information technology (IT) hiring.
2 mins
November 21, 2025
Mint Mumbai
Bluechips lift Street to a 13-month high
Eyes on Q3 earnings as Nifty crosses 26,200, FPIs turn positive
3 mins
November 21, 2025
Mint Mumbai
Delhi's toxic air: Do we have an adaptation plan?
The national capital has seen two citizen-led protests in November over worsening air quality in the region. Doctors have called the winter air pollution in Delhi a public health emergency, urging stringent measures. Mint explores the issue.
2 mins
November 21, 2025
Mint Mumbai
Automation hits tech jobs as GCCs too dial back on hiring
Quess ended last quarter with ₹3,832 crore in revenue, up 5% sequentially.
1 mins
November 21, 2025
Listen
Translate
Change font size